Home   |   ISSTD Member's Corner   |   Contact ISSTD
Follow Us:

Reflections on Clinical Practice and Clinical Research in Traumatic Stress || Held Saturday, April 27, 2013

POST CONFERENCE UPDATE  This conference was recorded and will be made available to view on demand in the near future. Please visit this site again for further information.

In our efforts to be environmentally friendly and "green" we are sending registrants the speaker handouts electronically for this workshop. 

CONTENT OVERVIEW: There have been great advances in the science of complex trauma and dissociation, particularly in the areas of the intergenerational transmission of trauma and dissociation, the neurobiological impact of trauma, and the treatment of individuals with complex trauma exposure and dissociation (Brand, Lanius & Loewenstein, in press). This conference will be an opportunity for clinicians to be made aware of these developments and learn how to alter their assessment and treatment practices with patients who have experienced complex trauma so that clinical treatment can keep pace with these developments. In discussions among researchers and clinicians, the need for increased integration of science and clinical practice has become increasingly evident. For example, few clinicians receive any training on dissociation and complex trauma despite these patients being quite highly prevalent among the general population and clinical groups (Brand & Loewenstein, 2010). Thus, they do not understand how to assess for difficulties related to complex trauma exposure, nor how to adapt treatment for these highly symptomatic and often chronically self-destructive and suicidal patients.

 The Conference Center at Sheppard Pratt

 The live regional seminar was held on April 27, 2013 at the Conference Center and Sheppard Pratt. overlooking beautifully landscaped grounds. Thisyear-round, state-of-the-art conference facility features a 200-seat auditorium, five climate-controlled classrooms, catering and dining services, videoconferencing services, comprehensive audio-visual services and free parking.


TOP DD Study: In this seminar, we will share findings and treatment implications of a recent 30 month, prospective naturalistic study, called the Treatment of Patients with Dissociative Disorders. This study has revealed that dissociative disorder (DD) patients showed decreased levels of dissociation, posttraumatic stress disorder symptoms, general distress, drug use, physical pain, and depression over the course of treatment (Brand, McNary, et al., 2012). As treatment progressed, patients reported increased socializing, attending school or volunteering, and feeling good. According to therapists’ reports, patients engaged in less self-injurious behavior and had fewer hospitalizations as well as increased GAF scores and adaptive capacities over time. These results suggest that treatment provided by therapists who have training in treating DD appears to be beneficial across a number of clinical domains (Brand, McNary, et al., 2012). Furthermore, the patients who had strong therapeutic alliance showed greater improvements in treatment, indicating that this aspect of the therapeutic relationship is critical to the success of treatment.


PLEASE VISIT AGAIN FOR INFORMATION AS IT BECOMES AVAILABLE TO VIEW THE RECORDED PROGRAM ON DEMAND

 OVERALL LEARNING OBJECTIVES

 At the end of this conference participants will be able to:

  1. Recognize the stages of treatment for complex, dissociative patients and which types of patients need supportive versus intensive trauma-focused treatment.
  2. Recall the core treatment interventions that are recommended for use across the treatment stages for complex, dissociative patients.
  3. State the regions of the brain that are involved in complex trauma survivors’ difficulties with self-awareness, emotion regulation, and social emotional processing.
  4. Recognize the maternal behaviors that increase risk for infants developing disorganized attachment, dissociation, and externalizing behaviors.
  5. Describe the interventions that are likely to be successful in preventing the multi-generational cycle of maltreatment.
 Faculty

 Click on photo/name to access bios.

 

 

 Bethany Brand, Ph.D. Ruth Lanius, M.D. Ph.D.  Richard J. Loewenstein, M.D.

 

 

 
 Richard P. Kluft, M.D., Ph.D.  Frank W. Putnam, M.D.


 Schedule

Times | Faculty |Sessions | Objectives  Back to Top
THIS PROGRAM WAS HELD LIVE ON SATURDAY, APRIL 27, 2013
 
 8:15 - 8:45 am | Registration & Continental Breakfast 
 8:45 am - 9:00am | Welcome Richard J. Loewenstein, M.D.
 9:00 am - 10:00 am | Session I Richard P. Kluft, M.D., Ph.D.
 "That's the reason they're called lessons," said the Gryphon, "because they lessen from day to day." -- Reflections on the Treatment of DID, 1970-2012.

 Objectives:

  • Define heterohypnosis, autoypnosis, and spontaneous trance.
  • List at least 8 of the over 20 models of dissociation in the contemporary literature.
  • Compare the concepts of integration and resolution.
 10:00 am - 10:15 am | Break 
 10:15 am - 11:15 am | Session II Ruth Lanius, M.D., Ph.D.
 “The Traumatized Self: Clinical and Neurobiological Perspectives”

  Objectives:

  • Describe the neurobiology of PTSD as related to early life trauma.
  • Discuss the neurobiological findings of PTSD related to early life trauma to the clinical presentation of the disorder.
  • Discuss the neurobiology of PTSD in relationship with treatment of the disorder.
 11:15 am - 11:30 am | Break 
 11:30 am - 12:30 pm | Session III    Bethany Brand, Ph.D.

“The Findings and Treatment Implications of the Treatment of Patients with Dissociative Disorders (TOP DD) Study”

 Objectives:

  • Recognize the impact of the therapeutic alliance on dissociative disorder patients’ progress in treatment.
  • Discuss the core treatment interventions that are recommended for use across the stages of treating individuals with dissociative disorders.
  • Summarize the findings of the TOP DD study.
 12:30 pm - 1:45 pm | Lunch 
 1:45 pm - 2:45 pm | Session IVRichard J. Loewenstein, M.D.
“Fundamental Things About Stage 1 Treatment of DID: All the Things You Were Afraid to Ask, Didn’t Know You Needed to Ask, Forgot to Remember to Ask, or Just Wanted to Know”

Objectives:

  • Identify the three most important issues in stage 1 of Phasic Trauma Treatment for DID.
  • Identify the forensic implications of a safety agreement in the treatment of DID.
  • Identify the importance of holding the DID patient responsible for the behavior of any personality state.
 2:45 pm - 3:00 pm | Break 
 
 3:00 pm - 4:00 pm | Session V     
Frank W. Putnam, M.D.
 “The Role of Dissociation in the Intergenerational Transmission of Child Abuse” 

Objectives:

  • Define Type D attachment and its relationship to maternal behaviors and child behavior problems.
  • Describe the role of Type D attachment, dissociation, and harsh parenting in the multi-generational cycle of maltreatment.
  • Discuss opportunities for intervention in the multi-generational cycle of maltreatment.
 Information about Continuing Education Credits Offered to Participants at Live Event on April 27, 2013

 ACCREDITATION STATEMENTS

Physician Accreditation: Sheppard Pratt Health System is accredited by the Accreditation Council for Continuing Education (ACCME) to provide continuing medical education for physicians. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Sheppard Pratt Health System and International Society for the Study of Trauma and Dissociation. Sheppard Pratt Health System is accredited by the ACCME to provide continuing medical education for physicians. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. Sheppard Pratt Health System designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Psychologist Accreditation: Sheppard Pratt Health System is authorized by the State Board of Examiners of Psychologists as a sponsor of Continuing Education. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. Sheppard Pratt Health System designates this educational activity for a maximum of 5.0 CE hours for Psychologists. Psychologists should claim credit commensurate with the extent of their participation in the activity.

Social Work Accreditation: Sheppard Pratt Health System is authorized by the Board of Social Work Examiners of Maryland to offer continuing education for Social Workers. Sheppard Pratt takes responsibility for the content, quality, and scientific integrity of this CME activity. This activity is approved for 5.0 CEU contact hours in Category 1 for Social Workers.

Counseling Accreditation: Sheppard Pratt Health System is an NBCC Approved Continuing Education Provider (ACEPTM) and may offer NBCC approved clock hours for events that meet NBCC requirements. The ACEP solely is responsible for all aspects of the program. This activity is designated for 5.0 contact hours for National Certified Counselors.

 DISCLOSURE STATEMENTS

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest.

In accord with Sheppard Pratt’s Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the AMA, the event coordinators, speakers, and planners have been asked to disclosure any relationships they have had with companies producing pharmaceuticals, medical equipment and other products, during the past 12 months, that might have relevance to the content of their presentations and which may be construed as a conflict of interest.

Faculty Disclosures:
Richard Kluft, M.D., reports having no financial relationships with any commercial interests or pharmaceutical companies.  He will not be discussing the uses of any pharmaceuticals or the off-label uses of pharmaceuticals in his presentation.

Ruth Lanius, M.D., Ph.D., reports having no financial relationships with any commercial interests or pharmaceutical companies.  She will not be discussing the uses of any pharmaceuticals or the off-label uses of pharmaceuticals in her presentation.

Bethany Brand, Ph.D., reports having no financial relationships with any commercial interests or pharmaceutical companies.  She will not be discussing the uses of any pharmaceuticals or the off-label uses of pharmaceuticals in her presentation.

Frank Putnum, M.D., reports having no financial relationships with any commercial interests or pharmaceutical companies.  He will not be discussing the uses of any pharmaceuticals or the off-label uses of pharmaceuticals in his presentation.

Richard Loewenstein, M.D., reports having no financial relationships with any commercial interests or pharmaceutical companies.  He will not be discussing the uses of any pharmaceuticals or the off-label uses of pharmaceuticals in his presentation.

Event Planners Disclosure:
The following event planners are reported as having no financial interest, arrangement or affiliation with commercial interests or pharmaceutical companies, over the past 12 months with pharmaceutical companies whose products may have relevance to the content of this presentation: Ellen Mongan, M.D., Drew Pate, M.D., Steven Sharfstein, M.D., Robert Roca, M.D., Faith Dickerson, Ph.D., Caroline Cahn, LCSW-C, Talya Nack, LCPC, Desmond Kaplan, M.D., Jennifer Tornabene, Therese Clemens and Bonnie Katz.

 ACKNOWLEDGEMENTS OF COMMERCIAL SUPPORT

 It is with great appreciation that we wish to acknowledge our In-Kind and Commercial Supporters for this Conference.

The following speakers donated their honoraria as In-kind Support: Richard Kluft, M.D.; Ruth Lanius, M.D., Ph.D.; Bethany Brand, Ph.D.; Frank Putnam, M.D.; Richard Loewenstein, M.D.

Sheppard Pratt Health System donated the Sheppard Pratt Conference Center space as In-Kind Support.

Towson University donated funds to be applied to speaker travel costs.

 Cancellation Policy for Live Event on April 27, 2013

Cancellations must be received in writing within (5) business days before the event. A cancellation fee will apply. There are no refunds for cancellations received less than (5) business days prior to the conference. No-shows will not be refunded.

For further information email Jennifer Russell at jrussell@isst-d.org ISSTD Headquarters today!
 Back to Top    
 SPECIAL THANKS
ISSTD expresses its sincere appreciation to Sheppard Pratt Health System staff, in particular the Sheppard Pratt Trauma Disorders Unit, under the direction of Richard J. Loewenstein, M.D.; our presenters, Bethany Brand, Ph.D.; Ruth Lanius, M.D., Ph.D., Richard J. Loewenstein, M.D.; Richard P. Kluft, M.D., Ph.D., and Frank W. Putnam, M.D.; Towson University; and our volunteer supporters without which this program would have been possible.
 

professional training:

Diagnostik und Behandlung traumatisierter Kinder und Jugendlicher
Learn more about the German training and register

Child & Adolescent Online Course will begin in January 2015

Learn more about the training course and register

ISSTD Center for Advanced Studies in Trauma and Dissociation
Offering two certificates in trauma and dissociation.
Go to further certificate program information...

ISSTD Webinar Series Continue
Members have free access to MHPN's webinar series
Learn more about ISSTD Webinars...

Quick Link -  Student Course Access
Access your course site here...